Related Experiment Video
Updated: Jun 13, 2025
Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
Published on: January 19, 2019
Immune evolution in pre-invasive lung adenocarcinoma
Adithya Balasubramanian1, Marie-Liesse Asselin-Labat2
1Personalised Oncology Division, the Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia; Department of Medical Biology, the University of Melbourne, Parkville, VIC, Australia; Department of Medical Oncology, Monash Health, Melbourne, VIC, Australia; Department of Medical Oncology, the Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Researchers mapped immune changes during lung adenocarcinoma (LUAD) progression. Identifying TIM-3 as a target could advance LUAD immunoprevention strategies.
Area of Science:
- Oncology
- Immunology
- Cancer Research
Background:
- Lung adenocarcinoma (LUAD) progression from precursor lesions to invasive disease is not well understood.
- Immune system dynamics during LUAD development are critical but largely uncharacterized.
Purpose of the Study:
- To investigate the dynamic immune microenvironment changes during the progression of lung adenocarcinoma.
- To identify potential therapeutic targets for lung adenocarcinoma immunoprevention.
Main Methods:
- Utilized high-resolution spatial mapping techniques to analyze immune cell infiltration and distribution.
- Examined the temporal immune landscape associated with LUAD precursor lesions and invasive tumors.
Main Results:
- Detailed mapping of dynamic immune alterations throughout LUAD progression.
- Identification of specific immune markers, including TIM-3, associated with disease advancement.
Conclusions:
- Immune microenvironment plays a crucial role in LUAD progression.
- TIM-3 emerges as a promising therapeutic target for developing novel lung adenocarcinoma immunoprevention strategies.
More Related Videos
Related Concept Videos
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...